Click on each name to view their bio.
Vice President of Laboratory Operations, Genesis Biotechnology Group
Pete joined the GBG team in 2000. As the Vice President of Laboratory Operations, he is responsible for the overall operation, and administration of all College of American Pathologists (CAP) accredited laboratories, including Molecular, Microbiology, Serology, and Pathology Divisions. He ensures the development of Standard Operating Procedures (SOP) and Quality Control/Quality Assurance programs. Pete is responsible for the recruitment and employment needs of all laboratory personnel, selection and maintenance of equipment, safety aspects, QA/QC, and proficiency testing. He takes the lead on all regulatory inspections, including CAP, Clinical Laboratory Improvement Act (CLIA), NJ Department of Health, NY Department of Health, and Occupational Safety and Health (OSHA) inspections. Pete serves as Quality Manager for all FDA-related projects as well as a CAP inspector for outside laboratories. Pete joined MDL as a Laboratory Technician in 2000 and has since held various positions of increasing responsibility, including Second Shift Coordinator, Third Shift Coordinator, Laboratory Manager, and Director of Laboratory Operations. In 2017 Pete was promoted to his current position of Vice President of Clinical Laboratory Operations. Pete received his BS in Biology from Rutgers University in New Brunswick, NJ.
Vice President of Laboratory Operations, Medical Diagnostic Laboratories
Kelly joined the GBG team in 2004. As the Vice President of Laboratory Operations, Kelly is responsible for overseeing and managing Medical Diagnostic Laboratories' clinical laboratory Customer Service, Quality Assurance, Quality Control, and the Clinical Laboratory. Kelly began her career with MDL as a Laboratory Technician in 2004. In 2005 she became a Clinical Validation Technician and transitioned into the role of Clinical Implementation/Validation Coordinator in 2007. In 2010 Kelly was promoted to Assistant Director of the QA & QC Department. She held this position until 2012, when she became Director of Quality Control. In 2017 Kelly was promoted to her current position of Vice President of Clinical Laboratory Operations. Kelly received her BS in Biology from Shippensburg University in Shippensburg, PA.
Olesia Buiakova, M.D., Ph.D.
Chief Scientific Officer, Genesis Drug Discovery & Development (GD3)
Dr. Buiakova joined the GBG team in 2013. As the Chief Scientific Officer of GD3 she inspires and drives innovation of new drug discovery and development platforms and pipelines for GD3 and member companies. Dr. Buiakova identifies opportunities for new collaborations and serves as a member of the GBG Executive Council. Dr. Buiakova began her career with GBG as the Vice President of Biology for Invivotek in 2013. Later that year, she transitioned into the role of Chief Scientific Officer of Invivotek. In 2021, Olesia became the Chief Scientific Officer of GD3, the parental company for all GBG contract research organizations. During her career outside of GBG, Dr. Buiakova held multiple positions of increasing responsibility, including Associate Director at Xenogen Biosciences, Director of the CRO Division of Taconic and Senior Director at Skyhawk Therapeutics with a concentration in in vivo pharmacology. She also spent three years at Columbia Genome Center at Columbia University, New York, NY, concentrating on generation and characterization of genetically modified animal models of human disease. Dr. Buiakova earned an MD in Medical Biochemistry at the Russian State Medical University in Moscow, Russia, a Ph.D. in Molecular Biology at the Institute for Molecular Genetics of the Russian Academy of Sciences in Moscow, Russia, and completed her post-doctoral fellowship in Molecular Neurobiology at Hoffmann-La Roche Institute for Molecular Biology in Nutley, NJ.
Deborah Giusto, MD
Chief Executive Officer, 4path
Dr. Giusto is board-certified in Anatomic and Clinical Pathology by the American Board of Pathology. She completed Pharmacy Curriculum at Lewis University in Romeoville, Illinois. She received both a Doctor of Pharmacy and Doctor of Medicine with honors from the University of Illinois in Chicago, Illinois. Dr. Giusto has published several abstracts and publications in peer-reviewed medical journals and contributed to a book chapter in a recently published authoritative textbook of liver pathology. Before earning her medical degree, Dr. Giusto was a pharmacist for ten years, working in an underserved area on the West Side of Chicago.
Martin Adelson, Ph.D.
Chief Operation Officer, Genesis Biotechnology Group
Dr. Adelson joined the GBG team in 2002. As the Chief Operating Officer, Dr. Adelson leads clinical, development, and discovery research operations in Medical Diagnostic Laboratories, L.L.C. (MDL), Venenum Biodesign, LLC, and Invivotek LLC, with his primary focus concentrating on scaling and expanding the existing business infrastructure through both organic growth and corporate acquisition. In addition, Dr. Adelson implements various innovations and re-engineering initiatives and leverages customized technology solutions to re-calibrate and enhance MDL’s workflow while reducing overall business costs. Prior to his appointment to Chief Operating Officer in 2013, Dr. Adelson held positions within MDL as Director of Research & Development before becoming Vice President of MDL in 2007. Dr. Adelson received his BS in Biology from The College of New Jersey (formerly Trenton State College) in Ewing, NJ. He earned his Ph.D. in Molecular Biology & Genetics from the Department of Molecular Biology and Genetics/Fels Institute for Molecular Biology and Cancer at Temple University School of Medicine in Philadelphia, PA.
Jing-Jing Yang, MD
Pathologist, Medical Diagnostic Laboratories, L.L.C.,
Laboratory Director, SunPath-MDL
Dr. Yang is board-certified in Anatomic and Clinical Pathology and Cytopathology by the American Board of Pathology. She completed the Post-Baccalaureate Pre-Med curriculum at Rutgers College, Rutgers University in New Brunswick, New Jersey. She then went on to receive her M.D. from St. George’s University, in Grenada, West Indies. Dr. Yang completed her Anatomic and Clinical Pathology Residency at St. Lukes-Roosevelt, Beth Israel Medical Center in New York, NY, a Fellowship in Cytopathology at Mt. Sinai Medical Center in New York, NY, and a Fellowship in Genitourinary Pathology at Cleveland Clinic in Cleveland, Ohio.